April 9 @ 12:05 PM – 12:50 PM
Interested in getting hands-on insights and help from subject matter and career experts within the industry?! Well, look no further than BioBuzz’s weekly virtual Ask Me Anything series.
BioBuzz is thrilled to welcome a different expert every Tuesday (from 12:05-12:50pm) as a perk of being part of our talent community. This week’s guest is:
Andrew Buscemi, Associate Director of Supply Chain, REGENXBIO Inc.
Who can attend these sessions?
YOU or anyone within BioBuzz’s immediate and extended talent community.
What is the format?
These 45-minute interactive virtual sessions are broken down as follows:
12:05pm – Welcome & Introductions
12:10pm – Expert presentation on a trending topic / best practices
12:20pm – Q&A [Pre-Submitted Questions}
12:35pm – Q&A [Open Floor]
12:50pm – Closing Remarks
ABOUT REGENXBIO
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.
Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes.
We are currently developing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. Our product candidates all utilize AAV viral vectors from our proprietary gene delivery platform, which we call our NAV® Technology Platform. In addition to our internal product candidate programs, we also selectively license our NAV® Vectors to other leading biotechnology companies.